Evidence map›Paper›PMID 35940909›Full record

ReviewCold Spring Harbor perspectives in biology2022

Endoplasmic Reticulum-Associated Protein Degradation.

Logesvaran Krshnan, Michael L van de Weijer, Pedro Carvalho

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 2 syntheses or guidelines pooled it, 157 citations in OpenAlex.

  1. Pooled it
  2. Squalene Epoxidase: Its Regulations and Links with Cancers.International journal of molecular sciences · 2024
    Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Logesvaran Krshnan *Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
Michael L van de Weijer *Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
Pedro CarvalhoSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
University of Oxford · GB

Funding

Biotechnology and Biological Sciences Research CouncilWellcome TrustWellcome Trust 202642/Z/16/Z
6 · The paper itself

Abstract

Misfolded, potentially toxic proteins in the lumen and membrane of the endoplasmic reticulum (ER) are eliminated by proteasomes in the cytosol through ER-associated degradation (ERAD). The ERAD process involves the recognition of substrates in the lumen and membrane of the ER, their translocation into the cytosol, ubiquitination, and delivery to the proteasome for degradation. These ERAD steps are performed by membrane-embedded ubiquitin-ligase complexes of different specificity that together cover a wide range of substrates. Besides misfolded proteins, ERAD further contributes to quality control by targeting unassembled and mislocalized proteins. ERAD also targets a restricted set of folded proteins to influence critical ER functions such as sterol biosynthesis, calcium homeostasis, or ER contacts with other organelles. This review describes the ubiquitin-ligase complexes and the principles guiding protein degradation by ERAD.

Indexed as

Endoplasmic Reticulum-Associated DegradationSaccharomyces cerevisiae ProteinsCell Cycle ProteinsEndoplasmic ReticulumLigasesProteasome Endopeptidase ComplexProtein FoldingProteolysisSaccharomyces cerevisiaeUbiquitinationUbiquitin-Protein LigasesUbiquitinsCell Cycle ProteinsLigasesProteasome Endopeptidase ComplexSaccharomyces cerevisiae ProteinsUbiquitin-Protein LigasesUbiquitins

Identifiers

PMID35940909
PMCPMC9732900
OpenAlexW4292283911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.